What is the address of AVLOUKOVA SOINS INFIRMIERS?

The registered office of AVLOUKOVA SOINS INFIRMIERS is located at Rue Vinâve 42, 4030 Liège.

Is AVLOUKOVA SOINS INFIRMIERS still active?

Yes. According to the CBE (2 October 2026) AVLOUKOVA SOINS INFIRMIERS is active, legal situation “Normale toestand”, started on 24 April 2013.

Is AVLOUKOVA SOINS INFIRMIERS registered on Peppol?

No, AVLOUKOVA SOINS INFIRMIERS is currently not registered on the Peppol network.

What is the enterprise number of AVLOUKOVA SOINS INFIRMIERS?

The enterprise number of AVLOUKOVA SOINS INFIRMIERS is BE0527941801.

When was AVLOUKOVA SOINS INFIRMIERS founded?

AVLOUKOVA SOINS INFIRMIERS was founded on 24 April 2013.

Who are the directors of AVLOUKOVA SOINS INFIRMIERS?

According to the 2025 annual accounts, the directors of AVLOUKOVA SOINS INFIRMIERS are: Irina AVLOUKOVA.

Is AVLOUKOVA SOINS INFIRMIERS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 April 2013; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did AVLOUKOVA SOINS INFIRMIERS make in 2025?

AVLOUKOVA SOINS INFIRMIERS posted a profit after taxes of € 155,048 in financial year 2025.

What is the revenue of AVLOUKOVA SOINS INFIRMIERS?

As a small company, AVLOUKOVA SOINS INFIRMIERS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 222,295.

AVLOUKOVA SOINS INFIRMIERS (Private Limited) - Liège

Dossier AVLOUKOVA SOINS INFIRMIERS, printed on 2 October 2026 from databakkes.be/en/0527941801/avloukova-soins-infirmiers. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

AVLOUKOVA SOINS INFIRMIERS from Liège, company number BE0527941801, closed financial year 2025 with a result of € 155,048 after tax. For that financial year AVLOUKOVA SOINS INFIRMIERS recorded a gross margin of € 222,295 and equity of € 382,779. Compared with financial year 2024, the result moved from € 150,734 to € 155,048. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 15, 2025.

What it is worth Growing

€ 382,779

▲ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 155,048

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 147,640

▲ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 52,038 paid out

34 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 200

▼ 65% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 18,868

▲ 200% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 201,984 Gross margin 2022: € 201,984 First fiscal year in the series	€ 205,874 Gross margin 2023: € 205,874 ▲ 2% vs 2022 (€ 201,984) Favourable step	€ 205,412 Gross margin 2024: € 205,412 Unchanged (€ 205,874) Unfavourable step	€ 222,295 Gross margin 2025: € 222,295 ▲ 8% vs 2024 (€ 205,412) Favourable step	▲ 8%
Profit after taxes	€ 139,050 Profit after taxes 2022: € 139,050 First fiscal year in the series	€ 146,593 Profit after taxes 2023: € 146,593 ▲ 5% vs 2022 (€ 139,050) Favourable step	€ 150,734 Profit after taxes 2024: € 150,734 ▲ 3% vs 2023 (€ 146,593) Favourable step	€ 155,048 Profit after taxes 2025: € 155,048 ▲ 3% vs 2024 (€ 150,734) Favourable step	▲ 3%
Equity	€ 155,643 Equity 2022: € 155,643 First fiscal year in the series	€ 209,036 Equity 2023: € 209,036 ▲ 34% vs 2022 (€ 155,643) Favourable step	€ 279,770 Equity 2024: € 279,770 ▲ 34% vs 2023 (€ 209,036) Favourable step	€ 382,779 Equity 2025: € 382,779 ▲ 37% vs 2024 (€ 279,770) Favourable step	▲ 37%
Total debts	€ 73,011 Total debts 2022: € 73,011 First fiscal year in the series	€ 118,392 Total debts 2023: € 118,392 ▲ 62% vs 2022 (€ 73,011) Unfavourable step	€ 86,752 Total debts 2024: € 86,752 ▼ 27% vs 2023 (€ 118,392) Favourable step	€ 72,381 Total debts 2025: € 72,381 ▼ 17% vs 2024 (€ 86,752) Favourable step	▼ 17%
Cash	€ 159,362 Cash 2022: € 159,362 First fiscal year in the series	€ 102,520 Cash 2023: € 102,520 ▼ 36% vs 2022 (€ 159,362) Unfavourable step	€ 138,319 Cash 2024: € 138,319 ▲ 35% vs 2023 (€ 102,520) Favourable step	€ 147,640 Cash 2025: € 147,640 ▲ 7% vs 2024 (€ 138,319) Favourable step	▲ 7%
Retained profit	€ 149,443 Retained profit 2022: € 149,443 First fiscal year in the series	€ 209,036 Retained profit 2023: € 209,036 ▲ 40% vs 2022 (€ 149,443) Favourable step	€ 279,770 Retained profit 2024: € 279,770 ▲ 34% vs 2023 (€ 209,036) Favourable step	€ 382,779 Retained profit 2025: € 382,779 ▲ 37% vs 2024 (€ 279,770) Favourable step	▲ 37%
Dividend	€ 43,500 Dividend 2022: € 43,500 First fiscal year in the series	€ 87,000 Dividend 2023: € 87,000 ▲ 100% vs 2022 (€ 43,500) Unchanged	€ 80,000 Dividend 2024: € 80,000 ▼ 8% vs 2023 (€ 87,000) Unchanged	€ 52,038 Dividend 2025: € 52,038 ▼ 35% vs 2024 (€ 80,000) Unchanged	▼ 35%
Balance sheet total	€ 228,654 Balance sheet total 2022: € 228,654 First fiscal year in the series	€ 327,428 Balance sheet total 2023: € 327,428 ▲ 43% vs 2022 (€ 228,654) Unchanged	€ 366,521 Balance sheet total 2024: € 366,521 ▲ 12% vs 2023 (€ 327,428) Unchanged	€ 455,160 Balance sheet total 2025: € 455,160 ▲ 24% vs 2024 (€ 366,521) Unchanged	▲ 24%

Key figures of AVLOUKOVA SOINS INFIRMIERS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to AVLOUKOVA SOINS INFIRMIERS?

What happened at AVLOUKOVA SOINS INFIRMIERS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 15, 2025 New annual accounts for financial year 2025: profit of € 155,048 (▲ 3% vs 2024). Source: NBB ↗
2013 Irina AVLOUKOVA became a director. NBB
Apr 24, 2013 Start of the company according to the CBE. KBO
Apr 17, 2013 New establishment in Liège. KBO

In short

From € 139,050 profit in 2022 to € 155,048 profit in 2025.

Paid € 229,401 in corporate taxes since 2022.

Best year ever: 2025, with € 155,048 profit.

Paid out € 262,538 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at AVLOUKOVA SOINS INFIRMIERS? We notify you, reason included.

Follow AVLOUKOVA SOINS INFIRMIERS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Irina AVLOUKOVA

AVLOUKOVA SOINS INFIRMIERS

Behind AVLOUKOVA SOINS INFIRMIERS is Irina AVLOUKOVA.

See the full network in the app

Directors

According to the 2025 annual accounts

Irina AVLOUKOVA

Director, Manager

since 2013

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Vinâve 42

4030 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0527.941.801
VAT number: BE 0527.941.801
Registered office: Rue Vinâve 42, 4030 Liège
Names & denominations: AVLOUKOVA SOINS INFIRMIERS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 April 2013
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗